NYSCF Scientists One Step Closer to Cell Therapy for Multiple Sclerosis

Types of MS (Photo credit: Wikipedia)

Scientists at The New York Stem Cell Foundation (NYSCF) Research Institute are one step closer to creating a viable cell replacement therapy for multiple sclerosis from a patient’s own cells.

For the first time, NYSCF scientists generated induced pluripotent stem (iPS) cells lines from skin samples of patients with primary progressive multiple sclerosis and further, they developed an accelerated protocol to induce these stem cells into becoming oligodendrocytes, the myelin-forming cells of the central nervous system implicated in multiple sclerosis and many other diseases.

Existing protocols for producing oligodendrocytes had taken almost half a year to produce, limiting the ability of researchers to conduct their research. This study has cut that time approximately in half, making the ability to utilize these cells in research much more feasible.

Stem cell lines and oligodendrocytes allow researchers to “turn back the clock” and observe how multiple sclerosis develops and progresses, potentially revealing the onset of the disease at a cellular level long before any symptoms are displayed. The improved protocol for deriving oligodendrocyte cells will also provide a platform for disease modeling, drug screening, and for replacing the damaged cells in the brain with healthy cells generated using this method.

“We are so close to finding new treatments and even cures for MS. The enhanced ability to derive the cells implicated in the disease will undoubtedly accelerate research for MS and many other diseases,” said Susan L. Solomon, NYSCF Chief Executive Officer.

Take me to the complete story . . .

The Latest on: Cell replacement therapy

[google_news title=”” keyword=”Cell replacement therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]

via Google News

The Latest on: Cell replacement therapy

Stem cell therapy: a potential cure for hearing loss?
on March 28, 2023 at 5:38 am
As stem cell research gains momentum, researchers are looking at ways to use the therapy to treat hearing loss.
CBD May be Able to Help You Quit Smoking. Here's How
on March 28, 2023 at 5:17 am
New research finds that CBD may be able to help people quit smoking in a number of ways, including by reducing cravings and easing anxiety.
Remedium and Exothera partner on scale-up of gene therapy for osteoarthritis
on March 27, 2023 at 5:21 am
Remedium Bio, a US biotech and Exothera, a Belgian CDMO, have established a collaborative agreement in relation to the US firm’s disease modifying gene therapy for osteoarthritis, AAV2-FGF18.
MRI-guided Radiation Therapy Systems Revenue to Top US$2.89 Billion by 2033; Hospital Segment to Lead Sales; Fact.MR Report
on March 27, 2023 at 3:00 am
The market for MRI-guided radiation therapy systems is currently valued at US$ 545.1 million and is anticipated to generate US$ 2.89 billion in sales by the end of 2033.
Post Cycle Therapy Sarms, Are Sarms Bad for You
on March 25, 2023 at 3:52 pm
SARMs are a promising new class of drugs with the potential to provide significant therapeutic benefits with fewer side effects than traditional drugs.
How mRNA vaccines could target everything from cancer to the plague
on March 25, 2023 at 9:00 am
Imagine visiting your doctor for a routine checkup, and on top of the usual shots — the annual flu or COVID vaccine—your doctor asks if you’d like to be vaccinated for cancer. All cancer— lung, ...
Animal studies show potential of new drug to curb painful hyperinflammation from osteoarthritis
on March 23, 2023 at 11:23 am
A team of researchers at the Keck School of Medicine of USC have found a drug with the potential for curbing painful hyperinflammation from osteoarthritis, according to results of an animal study.
Human stem cells used to create new type of biohybrid neural implant
on March 22, 2023 at 7:28 pm
Researchers at the University of Cambridge have developed a new type of neural implant that combines stem cells with electronics and has the potential to help amputees or those who’ve lost the use of ...
Potential relief for osteoarthritis moves to clinical trial after animal studies
on March 22, 2023 at 1:29 pm
One key immune receptor, GP130, recruits white blood cells to attack bacteria and viruses, but it also summons the attackers in response to broken pieces of cartilage from our own joints. The result ...
Global Cell Therapy Market Report 2023: Major Players Include Fibrocell Science, JCR Pharmaceuticals, PHARMICELL and Osiris Therapeutics
on March 21, 2023 at 6:38 am
This report provides strategists, marketers and senior management with the critical information they need to assess the market.The global cell therapy market is expected to grow from $9.02 billion in ...